What Cobot does

Cobot (Wuhan Cobot Technology Co., Ltd. / 武汉库柏特科技股份有限公司) is a Wuhan-based medical robotics company that develops and sells AI-enabled robotic systems to hospitals in China and selected overseas markets. Founded around 2015–2016 and operating with 200+ employees (50% in R&D), the company is organized around two product lines that share a common proprietary intelligent robot operating system called CobotSys. The first line is Ultrasound Robotics, comprising the Intelligent Native Autonomous Ultrasound Robot, the 5G-enabled Intelligent Native Remote Ultrasound Robot (master-slave tele-ultrasound with ≤200 ms closed-loop latency and force feedback), and the Intelligent Native Breast Ultrasound Robot (a 12-degree-of-freedom dual-arm system). The second line is the Pharmacy Robot Overall Solution, an integrated platform with five sub-modules — Smart Outpatient Pharmacy, Smart Inpatient Pharmacy, Smart PIVAS (Intravenous Admixture Services), Intelligent Medication Management Cabinets, and Smart Logistics — that automate receiving, dispensing, replenishment, IV admixture, ward storage, and end-to-end drug traceability. The flagship Tianji (天机) embodied ultrasonic robot is described as domestically pioneered, and the company claims the largest deployment base in China for outpatient pharmacy automation.

Underlying capabilities are anchored by 150+ invention patents (417 total IP applications) and 16 national/provincial R&D programs, with the technology stack spanning computer vision, 3D robotic recognition, real-time motion planning, visual-force multimodal perception, autonomous agents, AI-driven visual verification, and integrated HIS / automated medicine packer / healthcare insurance platform connectivity. Regulatory milestones include NMPA Class III Medical Device Registration (2022), NMPA Green Channel approval for the remote automatic ultrasound diagnostic system (2024), and selection for the 2025 MIIT/NMPA AI Medical Device National Innovation Task.

Cobot generates revenue through three streams: capital equipment sales of medical robots and smart pharmacy hardware to hospitals (with project-based customization, on-site engineering, training, and bundled after-sales service supported by a 20+-branch service network); professional services and recurring after-sales support; and managed services and software subscriptions (smart pharmacy management software, distributed medication management cloud platform, HIS integration software). Pricing is quote-based and not publicly disclosed. The company has cumulatively raised six rounds of equity (approximately RMB hundreds of millions) from Matrix Partners China, GGV Capital, Blueprint Ventures, Empower Investment, AlphaX Partners, China Create Capital, Wuhan Hi-Tech Holding, and Xiantao Hi-Tech Industrial Investment, operates six wholly owned regional subsidiaries across China (Beijing, Harbin, Guangdong, Shanghai, Chongqing, Shenzhen), and exports the Cooper Intelligent Subcontracting Verification Integrated Machine Series to Singapore, Canada, and the UAE — the latter achieving 300% year-over-year sales growth in 2025.

Name

Cobot

Legal name

武汉库柏特科技股份有限公司 (Wuhan Cobot Technology Co., Ltd.)

Website

https://cobotsys.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Cobot (Wuhan Cobot Technology Co., Ltd.) is a Wuhan-based medical robotics company that builds AI-enabled ultrasound robots and integrated smart pharmacy systems, sold primarily to Chinese hospitals with growing exports to Singapore, Canada, and the UAE.

Ownership category

akta.pro rank

Product category

Medical Robotics

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)

akta.pro primary industry

Healthcare & Assistive Robotics (HDAAAIAC)

akta.pro secondary industries

Industrial & Warehouse Robotics (HDAAAIAA), Robot Hardware, Actuators & Components (sensors, grippers, motors) (HDAAAIAL)

Keywords

• Medical robotics
• Ultrasound diagnostic robots
• Pharmacy automation
• Hospital logistics systems
• Intelligent robot platforms

Headquarters

HQ city

Wuhan

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Robot & Smart Pharmacy Hardware Sales: Sales of capital equipment to hospitals and medical institutions: intelligent ultrasound robots (autonomous, remote, breast), smart pharmacy robotic systems (outpatient, inpatient, PIVAS, medication management cabinets), and smart hospital logistics systems. Multi-year depreciation-driven sales with significant project-based customization. Includes international exports of the Cooper Intelligent Subcontracting Verification Integrated Machine line (300% YoY sales growth in 2025, exported to Singapore, Canada, UAE).
2. Professional Services & After-Sales Support: Project implementation services including on-site engineers, comprehensive solution support, full usage training, plus ongoing after-sales service (monthly call return visits, quarterly on-site visits, regular inspection and maintenance). Service network covers 20+ branches across provinces.
3. Managed Services & Software Subscriptions: Recurring revenue from smart pharmacy management software, AI-powered pharmacy platforms, distributed medication management cloud platform, and HIS integration software that orchestrates automated dispensing equipment, real-time inventory, and prescription management across hospital departments.

Go-to-market motion4 records

Core offering

Cobot (Wuhan Cobot Technology Co., Ltd.) develops and manufactures intelligent medical robotics systems, specializing in autonomous, remote, and breast ultrasound diagnostic robots as well as smart pharmacy automation suites for hospitals. Its offerings integrate proprietary AI vision, force-controlled manipulation, and the CobotSys robot operating system to enable clinical imaging and pharmacy workflows with reduced manual workload and standardized outcomes.

Product overview

Cobot (Wuhan Cobot Technology Co., Ltd.) operates a platform-plus-modules architecture for AI + medical robotics, organized around two product lines that share a common intelligent robot "brain" called CobotSys. The first line is Ultrasound Robotics, comprising three core robots: the Intelligent Native Autonomous Ultrasound Robot (AI-driven automated scanning with auto-reporting), the Intelligent Native Remote Ultrasound Robot (5G-enabled tele-ultrasound with force feedback and ≤200 ms latency), and the Intelligent Native Breast Ultrasound Robot (12-DOF dual-arm automated breast screening for Two Cancers Screening programs). The second line is the Pharmacy Robot Overall Solution, an integrated smart-pharmacy platform composed of five sub-modules — Smart Outpatient Pharmacy, Smart Inpatient Pharmacy, Smart Pharmacy Intravenous Admixture Services (PIVAS), Intelligent Medication Management Cabinets, and Smart Logistics — covering the full medication lifecycle from receiving, dispensing, replenishment, IV admixture, ward storage and delivery through end-to-end drug traceability. CobotSys, the proprietary intelligent robot operating system, and the Tianji ultrasonic embodied intelligent robot serve as the cross-cutting technology core that ties the ultrasound and pharmacy product lines together, enabling features such as 3D vision, AI visual verification, autonomous replenishment, and embodied intelligent ultrasound scanning.

Differentiator

Problem solved

Functional benefit

Brands

• CobotSys: The company's proprietary intelligent robot operating system (智能机器人大脑 / intelligent robot brain), positioned as the core technology platform for its AI+robotics medical solutions.
• Tianji (天机)
• Cooper Intelligent Subcontracting Verification Integrated Machine Series (库柏特智能分包核对一体机)

Products and services

• Intelligent Native Autonomous Ultrasound Robot

Quantifiable outcome

• 300% YoY sales growth in 2025 for the Cooper Intelligent Subcontracting Verification Integrated Machine line
• +6 more outcomes

Named customers4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability14 records

Feature10 records

Scale indicators18 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• GE HealthCare: Global ultrasound leader with growing AI-ultrasound capabilities (Caption Health). Directly comparable to Cobot's ultrasound product line and the most credible global incumbent threat as it integrates AI guidance into its installed ultrasound base.
• Intuitive Surgical: Global leader in surgical robotics (da Vinci) and the reference benchmark for medical robotics economics. Comparable to Cobot on business model (high-margin capital equipment + recurring service) and as the template for hospital-relationship-driven robotic adoption.
• Stryker: Diversified medical technology company with the Mako orthopedic surgical robot and a broad hospital-channel presence. Comparable as a medtech incumbent using robotics to expand hospital share, and as a potential strategic acquirer of niche AI-robotic platforms.
• Philips: Global leader in diagnostic imaging, including ultrasound with AI-assisted workflow tools. Comparable to Cobot as a broad incumbent pushing AI-augmented ultrasound and as a competitor for hospital procurement in tiered-healthcare settings.
• BD (Becton, Dickinson and Company): Global medical technology company with a substantial pharmacy automation and medication management business (BD Pyxis). Comparable to Cobot's pharmacy robotics line and a likely competitor in Chinese hospital pharmacy automation tenders.
• United Imaging Healthcare: Leading Chinese medical imaging and AI diagnostics company with CT, MR, ultrasound and digital healthcare offerings. Comparable to Cobot as a Chinese domestic competitor in AI-powered imaging, and a credible threat in autonomous ultrasound given its installed base.
• Mindray: China's largest medical device company with a broad portfolio spanning patient monitoring, in-vitro diagnostics, and medical imaging including ultrasound. Directly comparable to Cobot's ultrasound robotics line and a potential acquirer or competitor as Mindray builds out AI-driven ultrasound.

Emerging players

• Butterfly Network: US-listed AI-ultrasound company with handheld, AI-guided probes targeting point-of-care and democratized diagnostics. Comparable to Cobot's mission of democratizing Grade III-A ultrasound to grassroots clinics, though Butterfly's handheld form factor competes rather than overlaps directly.

Direct peers

• Omnicell: US-listed leader in hospital pharmacy automation (medication management cabinets, IV compounding, dispensing robotics). Closely comparable to Cobot's pharmacy automation suite in product, customer (hospital pharmacy), and recurring-revenue model.
• MicroPort Scientific Corporation: Chinese medical robotics player (e.g., Toumai laparoscopic robot, Skywalker orthopedic robot) with comparable hospital-channel and surgical/medical robotics focus. Closely aligned with Cobot on medical-robotics positioning and Chinese hospital GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cobotsys
• Facebookfacebook.com/cobotsys

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries6 records

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cobot